Amlodipine Besylate Tablet
Product Images NDC 70518-0297

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 70518-0297). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm2 (Amlodipine Besylate 10mg 70518 0297 01)

Label for Amlodipine Besylate 10 mg oral tablets showing quantity of 90 tablets. The label includes the NDC number 70518-0297-01 and indicates the manufacturer as Cipla USA, Inc., Miami, FL, with repackaging by RemedyRepack Inc., Indiana, PA. The tablets are round in shape and the label specifies storage temperature ranges and directions to see package insert for use.*

FDA Label Image

Mm3 (Amlodipine Besylate 10mg 70518 0297 02)

Label for Amlodipine Besylate 10 mg tablets, showing a quantity of 30 round tablets. The label includes NDC 70518-0297-02 and indicates repackaging by RemedyRepack Inc., Indiana, PA. Manufactured by Cipla USA, Miami, FL. Storage instructions and prescription-only designation are visible.*

FDA Label Image

Remedy_label (Remedy Label)

Label for Amlodipine Besylate 10 mg tablet, quantity 30, round shape. Manufactured by Cipla USA Inc., Miami, FL, repackaged by RemedyRepack Inc., Indiana, PA. Includes storage instructions and QR code. NDC 70518-0297-00 shown.*

FDA Label Image

Image (A70a0c69 Aa21 4ced Bf80 C3487876dffa 01)

Chemical structure of amlodipine besylate showing its molecular arrangement including rings, functional groups, and chemical bonds. The structure is depicted with labeled atoms and bonds corresponding to the active ingredient amlodipine besylate.*

FDA Label Image

Image2 (A70a0c69 Aa21 4ced Bf80 C3487876dffa 02)

A Kaplan-Meier event rate curve comparing Amlodipine and placebo groups over 24 months. The x-axis represents time in months, and the y-axis shows event rate. The graph includes hazard ratio, p-value, and 95% confidence interval data. Numbers at risk are displayed below the time axis.*

FDA Label Image

Image3 (A70a0c69 Aa21 4ced Bf80 C3487876dffa 03)

A forest plot displaying hazard ratios with 95% confidence intervals comparing Amlodipine to placebo across multiple patient subgroups including overall, age groups (<65, >=65), gender (male, female), baseline sitting systolic blood pressure, baseline vessel disease (multiple vessels), baseline vessels with stenosis, and PCI-stent strata. The horizontal axis represents the hazard ratio scale from 0.0 to 2.0, indicating effect favoring either Amlodipine or placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.